Bilaketaren emaitzak - Maria Frantzi

Ten Years of Proteomics in Bladder Cancer: Progress and Future Directions nork Maria Frantzi, Antonia Vlahou

Testu osoa

Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development nork Maria Frantzi, Akshay Bhat, Agnieszka Latosinska

Testu osoa

Promise and Implementation of Proteomic Prostate Cancer Biomarkers nork Agnieszka Latosinska, Maria Frantzi, Axel S. Merseburger, Harald Mischak

Testu osoa

Novel Strategy for Acquiring Metabolically‐Tagged Nascent Extracellular Vesicles: Implications for Identifying Surface Protein Markers of Extracellular Vesicles From Neuroblastoma... nork Hugo P. Markus, Edwin deJong, Manousos Makridakis, Maria Frantzi, Armağan Koçer

Testu osoa

Omics Derived Biomarkers and Novel Drug Targets for Improved Intervention in Advanced Prostate Cancer nork Maria Frantzi, Marie C. Hupe, Axel S. Merseburger, Joost P. Schanstra, Harald Mischak, Agnieszka Latosinska

Testu osoa

Molecular Changes in Tissue Proteome during Prostate Cancer Development: Proof-of-Principle Investigation nork Agnieszka Latosinska, Katarina Davalieva, Manousos Makridakis, William Mullen, Joost P. Schanstra, Antonia Vlahou, Harald Mischak, Maria Frantzi

Testu osoa

Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma nork Torsten Voigtländer, Jochen Metzger, Holger Husi, Martha M. Kirstein, Martin Pejchinovski, Agnieszka Latosinska, Maria Frantzi, William Mullen, Thorsten Book, Harald Mischak, Michael P. Manns

Testu osoa

Dynamics in kidney function markers as predictors of post-ICU survival: an innovative approach to enhance marker accuracy nork Jakob Landau, Jakob Landau, Irene Unterman, Keren Tzukert, Maria Frantzi, Harald Mischak, Louis Boutin, Louis Boutin, Louis Boutin, Louis Boutin, François Depret, François Depret, François Depret, François Depret, Agnieszka Latosinka, Yaron Ilan

Testu osoa